8 Hone Health alternatives in 2026.

Vane is the only platform on this list that combines hormone, metabolic (GLP-1), vitality, sexual health, hair, and whole-health inside a single app subscription. Diagnosis follows the Endocrine Society 2018 guideline (Bhasin et al.): persistent symptoms plus two confirmatory morning fasting total testosterone draws below 264 ng/dL, or compelling clinical signs in the equivocal range. The Clarity symptom check uses the validated ADAM questionnaire (Morley 2000) before any labs are ordered. This is the closest thing on the market to how a careful endocrinologist would actually work a low-T workup, packaged as a consumer app.

Where Vane separates from Hone, Maximus, and the rest is the layer between visits. The AI Coach is Claude-powered with persistent chart memory; it reads each new panel in plain English, drafts what the clinician is likely to recommend, and routes anything material to a licensed physician. The Free tier gives members 8 Coach messages per day. Basic at $8.99/mo unlocks unlimited Coach access and chart memory. Premium at $85/mo is the clinical tier: titrated protocols, quarterly retests included, GLP-1 access, and async clinician messaging built into the app rather than sold as a separate concierge package.

Limitations to be honest about: Vane is newer than Hone or Defy, brand recognition is still building, and the native Android app is on the roadmap rather than shipped. The full clinical layer lives in Premium at $85/mo, which sits above the $45/mo Hone Premium entry tier. Members who only want testosterone at the cheapest possible price and no GLP-1, no AI layer, and no multi-program access will find the app priced for a different job.

Maximus built its early audience around enclomiphene, a selective estrogen receptor modulator that stimulates endogenous testosterone production rather than replacing it. For men under 45 with fertility intent and intact hypothalamic-pituitary-gonadal function, that is a defensible first-line and the literature supports it. The brand is tech-forward, lab-aware, and reads as a step up from a generic TRT mill. Their hormone-protocol writing is more rigorous than Hone's.

The limitations come from focus. Maximus is hormone-only, with peptide and ancillary add-ons; there is no GLP-1 program, no multi-program app subscription, and no AI Coach layer that carries the chart between visits. The brand register skews biohacker-adjacent, which is the right voice for the Optimizer persona but may feel performative to the Quiet Decliner or Reluctant Convert profiles. Retesting cadence and clinician depth are less transparent than at Vane or Defy.

Defy is one of the longest-running men's hormone clinics in the United States and the clinical depth shows. The formulary is broader than Hone's: testosterone cypionate, enclomiphene, HCG, peptides, growth hormone secretagogues, and ancillaries. They will run a full panel, they will retest, and the clinicians have meaningful tenure in the field. If your priority is "a clinic that has been doing this since before TRT was a marketing category," Defy is on a short list.

What Defy lacks is the consumer-app and AI layer. There is no Coach, no chart-memory product, no Apple Watch integration, no native mobile app that translates labs into plain English. The brand register is clinical-old-school rather than editorial, the website does not transparently price the membership, and onboarding has more friction than the app-first alternatives. For members who want depth without the friction, Vane is the closer fit; for members who want depth and are willing to navigate the legacy intake, Defy still earns the spot.

Marek built its audience in the performance and bodybuilding adjacent communities and has since broadened. The clinical work is real: full panels, retest cadence, ancillary protocols (HCG to preserve testicular function, anastrozole when E2 trends symptomatic, peptide options). Members get a more aggressive optimisation posture than at a mainstream clinic like Hone.

The trade-off is fit. Marek's brand and content register skew toward the Optimizer persona and further into performance culture. For the Quiet Decliner who wants competence without the gym-bro overlay, the experience can feel like the wrong room. Single-vertical: no GLP-1 program, no multi-program membership, no app-resident AI Coach that drafts the lab read. If you want depth and you live in that culture, Marek is a defensible pick. If you do not, Vane delivers similar clinical posture in a different register.

Henry is one of the more credible GLP-1 telehealth brands and has added a TRT track. For members whose actual job-to-be-done is metabolic, that ordering may match how they think about the problem. Pricing on the GLP-1 side is competitive, and Henry has been more transparent than some peers about compounded vs. branded medication, which matters in 2026 given the tightened FDA stance on compounded semaglutide.

On the hormone side, Henry is thinner than the dedicated hormone clinics. Less protocol variety, less transparent retest cadence, less depth on estradiol management or fertility-preserving options. The pairing of hormone and GLP-1 exists at Henry but is not the central pitch and does not have the integrated chart-memory layer that Vane Premium offers. If hormone is the primary job, this is not the right shop.

Hims is the most accessible and most recognisable brand in this category. The price is right, the funnel is fast, and for narrow single-symptom jobs (sildenafil for ED, finasteride for hair, basic low-T) it does what it says. As a public company, the operating discipline is real and the experience is polished.

The limitation is clinical depth. Hims is a single-symptom shop optimised for volume; the panel is shallow, the retest cadence is not the product, and there is no concierge-style protocol management. For men whose actual diagnosis would benefit from a 13-marker panel and a titrated protocol, Hims does not run that workup. The brand register also reads consumer-marketing, which the editorial-noir target persona may find off-putting.

Function Health is the strongest labs-only product in this segment. The panel breadth is real, the lab-data presentation is excellent, and at $499/year it is priced well for what it is. For members who already have a clinician and just want more data to bring to that relationship, Function does that job better than the entry-tier panels at any hormone clinic.

It does not, however, replace any of the platforms above. Function does not prescribe, does not titrate, does not run a protocol, and does not have a clinician-of-record for ongoing care. If your goal is to act on the labs, you still need a Vane, Defy, or comparable clinician layer on top. Treating Function as a Hone alternative is a category error; treating it as the lab layer underneath your hormone care is reasonable.

Lifeforce bundles a labs program, a coach, and a clinician-prescribed protocol into a single $349/mo membership. The branding is premium, the production values are high, and members get a coordinated experience across markers, coaching, and prescriptions. For members who want a single all-in number rather than a la carte, the pricing is honest about what is included.

The trade-off is focus. Lifeforce is not men-specific; the product covers women and men, and the protocol library is broader and less hormone-deep than at a dedicated men's hormone clinic. There is no AI Coach with chart memory in the Vane sense; the "coach" is human and lower-frequency. At $349/mo, the price sits well above Vane Premium ($85/mo) without the men-focused multi-program depth or the AI layer.